Best of JAMA 2025: Episode 6:Glucagon-Like Peptide-1 Receptor Agonists and Risk of Neovascular Age-Related Macular Degeneration

This research study investigates a potential link between popular metabolic medications and a serious vision-threatening condition known as neovascular age-related macular degeneration. By analyzing a massive database of elderly patients with diabetes, scientists discovered that those who used GLP-1 receptor agonists for at least six months faced double the risk of developing this specific eye disease compared to those not taking the drugs. The findings highlight a critical need for clinicians to weigh the systemic benefits of these treatments against possible long-term ocular complications. Ultimately, the study calls for deeper investigation into the biological reasons behind this association to ensure the safe management of patients on long-term therapy.